Teleflex Launches the LMA® Gastro™ Airway for Airway Management During Endoscopic Procedures
Global airway management provider launches innovative technology to address airway management challenges associated with endoscopic procedures.
The LMA® Gastro™ Airway is the first laryngeal mask designed specifically to facilitate esophageal access and promote airway control during endoscopic procedures.
The use of moderate-to-deep sedation during endoscopy is a common
practice around the world. Respiratory depression from sedative drugs
and airway obstruction requiring intervention are known risks associated
with endoscopic procedures, with studies demonstrating that hypoxemia
can occur in 11-50% of cases.1-3 In
The LMA® Gastro™ Airway is the latest innovation by
The LMA® Gastro™ Airway also features Cuff Pilot™ Technology – an integrated, cuff pressure indicator that constantly monitors cuff pressure, detecting changes resulting from fluctuations in temperature, nitrous oxide levels and movements within the airway. It provides at-a-glance feedback, highlighting changes that could affect patient safety.5 The continuous control of intracuff pressure through in-line (or integrated) cuff pressure monitoring has been clinically shown to reduce the risk of post-operative airway morbidity or leaks.5,6 In addition, the LMA® Gastro™ Airway has an integral bite block to reduce the potential for damage to the endoscope due to biting, helping to avoid costly repairs.
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
- Cote GA, Hovis RM, Ansstas MA, et al. Incidence of sedation-related complications with propofol use during advanced endoscopic procedures. Clin Gastroenterol Hepatol. 2010;8(2):137-142.
- Qadeer MA, Rocio Lopez A, Dumot JA, Vargo JJ. Risk factors for hypoxemia during ambulatory gastrointestinal endoscopy in ASA I-II patients. Dig Dis Sci. 2009;54(5):1035-1040.
de Paulo GA, Martins FP, Macedo EP, Goncalves ME, Mourao CA,
FerrariAP. Sedation in gastrointestinal endoscopy: a prospective study comparing nonanesthesiologist-administered propofol and monitored anesthesia care. Endosc Int Open. 2015;3(1):E7-E13.
Peery AF, Dellon ES, Lund J, et al. Burden of gastrointestinal disease
the United States: 2012 update. Gastroenterology. 2012;143(5):1179-1187 e1171-1173.
- Martin DP, Bhalla T, Thung A, Tobias JD. Clinical evaluation of a novel LMA with a color-coded pressure gauge. Int J Pediatr Otorhinolaryngol. 2013;77(1):76-78.
- Wong DT, Tam AD, Mehta V, Raveendran R, Riad W, Chung FF. New supraglottic airway with built-in pressure indicator decreases postoperative pharyngolaryngeal symptoms: a randomized controlled trial. Can J Anaesth. 2013;60(12):1197-1203.
Treasurer and Vice President, Investor Relations